Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Dec 12, 2016 $15.20 $15.20 $13.68 $14.32 135 993
Dec 09, 2016 $15.92 $16.40 $15.12 $15.28 181 165
Dec 08, 2016 $15.28 $16.64 $14.72 $16.00 385 465
Dec 07, 2016 $13.68 $20.24 $13.04 $16.24 3 169 218
Dec 06, 2016 $12.00 $12.16 $11.68 $11.76 39 566
Dec 05, 2016 $11.20 $12.40 $11.20 $12.00 76 202
Dec 02, 2016 $11.12 $12.00 $10.64 $12.00 71 628
Dec 01, 2016 $12.00 $12.00 $10.72 $10.88 95 254
Nov 30, 2016 $14.24 $14.32 $11.76 $12.00 161 690
Nov 29, 2016 $14.16 $14.40 $13.84 $14.08 52 032
Nov 28, 2016 $14.40 $14.48 $14.00 $14.16 33 720
Nov 25, 2016 $14.40 $14.40 $14.00 $14.24 36 466
Nov 23, 2016 $14.16 $14.64 $14.00 $14.48 39 477
Nov 22, 2016 $14.40 $14.80 $14.08 $14.48 52 715
Nov 21, 2016 $14.64 $14.88 $14.00 $14.48 60 829
Nov 18, 2016 $15.12 $15.28 $14.40 $14.64 68 937
Nov 17, 2016 $15.04 $15.60 $14.72 $15.12 76 665
Nov 16, 2016 $15.36 $15.76 $14.96 $15.12 46 166
Nov 15, 2016 $15.44 $15.92 $14.72 $15.52 68 838
Nov 14, 2016 $15.52 $15.92 $15.28 $15.60 73 697
Nov 11, 2016 $14.56 $15.92 $14.48 $15.60 173 258
Nov 10, 2016 $17.52 $18.72 $13.76 $15.20 727 210
Nov 09, 2016 $20.32 $22.48 $20.08 $22.24 112 681
Nov 08, 2016 $19.68 $19.68 $19.68 $19.68 42 987
Nov 07, 2016 $19.44 $19.44 $19.44 $19.44 46 563
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT